The U.S. 503B compounding pharmacies market involves the compounding of drugs in outsourcing facilities as per specific prescriptions for individual patients. These pharmacies offer advantages like compounding medications from bulk drug substances to create personalized medication doses, flavors and formulations. There has been increasing demand for such medications for pediatric and geriatric applications along with people needing variations of commercially available drugs. The Global 503B compounding pharmacies market is estimated to be valued at US$985.6 Mn in 2025 and is expected to exhibit a CAGR of 7.6% over the forecast Get More Insights On U.S. 503B Compounding Pharmacies Market https://ojaswini7.hashnode.dev/us-503b-compounding-pharmacies-market-is-estimated-to-witness-high-growth-owing-to-increasing-demand-for-specialty-and-niche-therapies?showSharer=true